At a Glance
| Topic | Key Facts |
|---|---|
| What it is | A single device that measures blood glucose and blood pressure, sometimes with a pulse oximeter |
| Who benefits most | Adults managing type 2 diabetes with comorbid hypertension |
| Comorbidity rate | Approximately 2 in 3 people with type 2 diabetes also have high blood pressure (ADA, 2025) |
| Accuracy standard | FDA requires blood glucose meters to read within 15% of a lab value; validated BP monitors should meet ISO 81060-2 standards |
| Insurance coverage | Blood glucose supplies are often covered by insurance; blood pressure monitors generally are not, but FSA/HSA funds typically apply to both |
| When to see a doctor | Any new dual diagnosis, readings consistently outside target range, or questions about device accuracy |
Managing two chronic conditions at home means tracking two sets of numbers and using two devices. For the roughly 37 million Americans living with diabetes, a significant portion of whom also live with high blood pressure, that daily monitoring routine adds up quickly. A blood glucose and blood pressure monitor that handles both in one device sounds like a practical solution. But how well do these combo devices actually perform?
This guide covers what 2-in-1 monitors are, how they compare to dedicated devices, and which products are currently available, so readers and their care teams can make informed choices. Understanding the connection between hypertension, heart disease, and related conditions is a useful starting point for anyone managing both diagnoses at home.
Why Monitoring Both Blood Glucose and Blood Pressure Matters in Diabetes
The connection between blood glucose and blood pressure is not coincidental. Both conditions share underlying biological mechanisms, and each tends to make the other harder to manage.
According to the American Diabetes Association's 2025 Standards of Care, approximately two in three people with type 2 diabetes also have hypertension or take medication to control blood pressure. In a 2018 review published in the British Journal of Diabetes, researcher Dr. David Laight noted that hypertension and diabetes share common pathophysiological pathways, including insulin resistance, endothelial dysfunction, and chronic low-grade inflammation, meaning that treating one condition without monitoring the other may leave part of the clinical picture unaddressed.
"Hypertension and diabetes share pathophysiological mechanisms and commonly coexist, increasing the risk of macro- and microvascular complications." -- Laight DW, British Journal of Diabetes, 2018
High blood glucose levels gradually damage the walls of blood vessels, reducing their elasticity and contributing to higher resting blood pressure. Elevated blood pressure, in turn, can accelerate damage to the kidneys and eyes, organs that are particularly sensitive to the macrovascular and microvascular complications of diabetes. Managing both conditions together gives people and their care teams a fuller picture between clinical visits.
Home monitoring of both readings supports that approach. The American Heart Association recommends that anyone diagnosed with high blood pressure monitor at home regularly, noting that home readings often reflect a person's true baseline more accurately than readings taken during a clinic visit.
Target ranges for adults with diabetes (a doctor can advise on individual targets):
| Measurement | Standard Target |
|---|---|
| Fasting blood glucose | 80--130 mg/dL (ADA, 2025) |
| Post-meal blood glucose (2 hours after eating) | Less than 180 mg/dL |
| A1C | Less than 7% for most adults |
| Home blood pressure | Less than 130/80 mmHg (ADA/AHA, 2025) |
A doctor can advise on whether individual targets differ based on age, kidney function, or other health factors.
How 2-in-1 Glucose and Blood Pressure Monitors Work
A true 2-in-1 blood glucose and blood pressure monitor combines two separate measurement systems into one device chassis. These are not the same technology. Blood glucose measurement and blood pressure measurement operate on entirely different principles, so the "combo" label can mean different things depending on the product.
Blood glucose measurement in home devices uses electrochemical detection. A small blood sample from a finger prick is applied to a disposable test strip. The strip contains enzymes that react with glucose, producing an electrical current that the meter reads and converts into a mg/dL or mmol/L value.
Blood pressure measurement uses oscillometry. An inflatable cuff detects oscillations in arterial blood flow as it deflates, calculating systolic and diastolic pressure along with pulse rate. The American Heart Association recommends upper-arm cuff monitors as more reliable than wrist or finger models for home use.
In a 2-in-1 device, these two systems typically share:
- A single housing or connected unit
- One display screen for both readings
- One set of batteries or charging port
- In Bluetooth-enabled models, one app for data logging
Some devices marketed as "2-in-1" are actually two separate devices sold together in a bundle, a glucometer and a blood pressure monitor packaged as a set, each functioning independently. True integrated devices measure both from the same hardware unit. Buyers should confirm which type they are purchasing before ordering.
A smaller category of devices adds pulse oximetry (SpO2 measurement) as a third metric. These are covered in the section on pulse oximeter and glucose monitor combinations below.
Best Combo Devices: Omron, Bayer, TD-3223 Reviewed
The 2-in-1 blood pressure and glucose monitor market is smaller than the market for dedicated devices. Below is an overview of the most commonly searched combo options, based on available product specifications and published accuracy information.
TD-3223: 2-in-1 Blood Glucose and Blood Pressure Monitor
The blood glucose and blood pressure monitor TD-3223 is one of the few true integrated devices currently available in the US market. It combines an upper-arm blood pressure cuff with a glucometer that uses standard test strips.
Key specifications (TD-3223):
| Feature | Detail |
|---|---|
| Blood glucose range | 20--600 mg/dL |
| Blood pressure range | 0--280 mmHg systolic |
| Memory | Typically 60 readings per function |
| Connectivity | Varies by model; some include USB data transfer |
| Test strip type | Proprietary; confirm compatibility before purchasing |
| Display | Single LCD screen |
What it does well: The TD-3223 consolidates two routine measurements into one device, reducing the number of separate tools required for daily monitoring. It suits people who test both readings on a set schedule and want a straightforward, low-tech option.
Limitations: Independent clinical validation data for the TD-3223 is more limited than for devices from established dedicated-device manufacturers. Proprietary test strips may increase ongoing costs, and the device lacks Bluetooth connectivity for automatic data logging.
A doctor can advise on whether the TD-3223 meets the accuracy requirements for a specific monitoring protocol.
Omron Blood Pressure Monitors and Glucose Monitoring
Omron is primarily known for its blood pressure monitors, which are among the most clinically validated home BP devices available. According to Omron Healthcare's product information, many of their upper-arm monitors are designed to meet Association for the Advancement of Medical Instrumentation (AAMI) and British Hypertension Society (BHS) validation standards.
Important clarification: As of 2026, Omron does not manufacture a true 2-in-1 blood glucose and blood pressure monitor. Searches for "blood glucose monitor Omron" or "Omron glucose monitor price" frequently surface their blood pressure devices, or bundles from third-party sellers pairing an Omron BP cuff with a separate glucometer from another brand. Shoppers should verify whether a product is a genuine integrated unit or a bundled set before purchasing.
Omron's standalone blood pressure monitors pair well with a separate dedicated glucometer. Their upper-arm monitor lines include Bluetooth-enabled models with app-based data logging through the Omron Connect platform.
What to look for in an Omron blood pressure monitor:
| Feature | Why it matters |
|---|---|
| AAMI/BHS/ESH clinical validation | Confirms the device meets accepted accuracy standards |
| Upper-arm cuff (not wrist) | AHA recommends for more reliable home readings |
| Irregular heartbeat detection | Flags arrhythmia during measurement |
| Bluetooth/app connectivity | Enables trend tracking and shareable data logs |
| Multi-user memory | Useful for households where two people monitor BP |
Bayer Glucose Monitor (Now Ascensia CONTOUR)
Bayer's diabetes division was acquired by PHC Holdings and rebranded as Ascensia Diabetes Care. The product line historically associated with Bayer, including the CONTOUR series, offered multiple testing and logging features. The current Ascensia CONTOUR NEXT ONE is a Bluetooth-enabled glucometer that syncs readings to the CONTOUR DIABETES app. It does not measure blood pressure.
The "12-in-1" descriptor occasionally appearing in searches for Bayer glucose monitors refers to multi-feature data functionality, including pre/post meal tagging, trend analysis, and multi-period averages, rather than 12 distinct physiological measurements.
For users seeking a glucometer to pair separately with a validated BP monitor, the CONTOUR NEXT ONE is a widely used option. A doctor or diabetes educator can advise on whether it suits a specific monitoring plan.
FORA D40: A True Integrated 2-in-1 Option
The FORA D40 series from ForaCare is one of the most established true 2-in-1 devices in the US market. It combines an upper-arm blood pressure monitor with a blood glucose meter in a single unit.
Key features:
- Blood glucose testing with a 0.5 µL sample size
- Upper-arm blood pressure cuff (standard and large sizes available)
- Audible results in English and Spanish
- Bluetooth connectivity to the ForaCare app (select models)
- LTE-enabled models available for remote patient monitoring programs
The FORA D40 is used in some telehealth and remote patient monitoring programs, where a care team reviews transmitted readings directly. This adds a layer of clinical oversight that standard consumer devices do not provide on their own.
Accuracy Comparison: Dedicated Devices vs. Combo Monitors
Accuracy is the central question for anyone considering a combo device. Dedicated devices generally have more published validation data than combo devices, though the practical significance of that gap depends on the individual's clinical situation.
Blood glucose accuracy:
The FDA requires home blood glucose monitors to produce results within 20% of a reference laboratory value, with current guidance recommending within 15%. The ADA's 2025 Standards of Care recommend meters that achieve results within 5% of laboratory values. Dedicated glucometers from established brands such as Ascensia CONTOUR, Abbott FreeStyle, and Roche Accu-Chek consistently meet or exceed these benchmarks in published studies.
Published accuracy data for most 2-in-1 devices is more limited. Devices in this category are designed to meet the FDA's 15% standard, but fewer have published head-to-head data against laboratory reference methods. Knowing how to calibrate a glucose meter and use it correctly is just as important as the device's accuracy rating, since user technique affects the reliability of every reading.
Blood pressure accuracy:
The benchmark for home BP accuracy validation is ISO 81060-2, administered through protocols from the Association for the Advancement of Medical Instrumentation. The American Heart Association recommends confirming whether a device appears on the validated device list at validatebp.org before purchasing.
Most dedicated upper-arm Omron monitors appear on that validated device list. Fewer 2-in-1 combo devices have undergone the same independent validation process.
Summary: dedicated vs. combo device accuracy
| Factor | Dedicated Devices | 2-in-1 Combo Devices |
|---|---|---|
| Published accuracy data | Extensive for leading brands | Limited for most models |
| Clinical validation | Many meet ADA/AHA standards | Fewer independently validated |
| Glucose accuracy | Generally within 5--15% of lab values | Designed to meet 15% FDA standard |
| BP validation (validatebp.org) | Most major brands listed | Few listed |
| App/data integration | Strong for Bluetooth-enabled models | Varies by model |
| Ongoing strip cost | Standard strips widely available | May require proprietary strips |
A doctor can advise on whether the accuracy profile of a specific combo device is appropriate for an individual's monitoring needs, particularly for people on insulin therapy where glucose precision carries more clinical weight.
Pulse Oximeter with Glucose Monitor: What's Available?
A pulse oximeter measures blood oxygen saturation (SpO2) and pulse rate using light sensors placed on a fingertip. It does not measure blood glucose. The two technologies are fundamentally different, and no FDA-cleared consumer device currently measures blood glucose non-invasively through the skin.
Searches for "pulse oximeter with glucose monitor" are common, but they reflect a gap between what consumers expect and what current technology can deliver. Non-invasive blood glucose sensing remains an active area of research. The FDA has issued a safety communication warning against relying on smartwatches or rings that claim to measure blood glucose without a finger-stick sample, as these devices are not cleared for that purpose.
What does currently exist:
- Combo pulse oximeter and blood pressure monitors: Wrist devices that measure SpO2 and BP exist but are generally less accurate for blood pressure than upper-arm monitors, per AHA guidance.
- Bundled monitoring kits: Some health monitoring kits sold online include a separate pulse oximeter and a glucometer packaged together. These are not integrated devices.
- Remote patient monitoring platforms: Some clinical programs for patients with COPD, heart failure, or diabetes use connected device ecosystems that transmit glucose, BP, and SpO2 readings separately to a care team. These require clinical enrollment and a referral.
Anyone using a pulse oximeter alongside a glucose monitor should treat them as separate tools until integrated and FDA-cleared technology becomes available.
Who Should Consider a Combo Monitor?
A 2-in-1 blood glucose and blood pressure monitor is not the right fit for everyone, but it suits specific circumstances well. The considerations differ somewhat depending on whether a person has type 1 or type 2 diabetes, as glucose monitoring frequency and precision requirements vary between the two.
Likely to benefit:
- Adults with type 2 diabetes and hypertension who test both readings daily and want a simplified routine
- Older adults or those with dexterity limitations who find managing two separate devices difficult
- Travelers or people with limited storage space
- Patients in remote monitoring programs where a certified combo device is provided by a care team
- Caregivers managing a family member's monitoring routine
Less likely to benefit:
- People on insulin therapy where tight glucose accuracy is clinically significant, and a dedicated glucometer with strong published validation may be preferable
- Individuals whose primary condition is hypertension only, with no glucose monitoring requirement
- Those who already own validated, accurate individual devices in good working order
- Anyone whose insurance covers a specific glucometer model but not combo devices
A doctor who specializes in diabetes management or internal medicine can advise on whether a combo device meets the accuracy requirements for a specific treatment plan.
Insurance and FSA/HSA Coverage for Combo Devices
Coverage for glucose monitoring supplies and blood pressure monitors differs under most US insurance plans, and coverage for combo devices is less straightforward than for dedicated devices.
Blood glucose monitoring supplies:
Medicare Part B covers blood glucose meters and test strips for people with diabetes who use insulin, and in some cases for non-insulin-dependent patients when medically necessary. Most commercial insurance plans follow similar guidelines. Coverage typically requires the device to be categorized as durable medical equipment (DME) and may be limited to specific approved models. The Medicare coverage database provides current guidance on eligibility criteria.
Blood pressure monitors:
Standard health insurance plans, including Medicare, generally do not cover the cost of home blood pressure monitors as durable medical equipment. Some insurers cover them when prescribed by a physician as part of a hypertension management program, but this is not universal. Reviewing what health insurance typically covers can help clarify what to expect before contacting a plan's member services line.
FSA and HSA eligibility:
Both blood glucose monitors and blood pressure monitors are typically eligible for purchase with Flexible Spending Account (FSA) or Health Savings Account (HSA) funds, as confirmed by IRS Publication 502, which lists qualified medical expenses. Test strips, lancets, and replacement cuffs are also generally FSA/HSA-eligible. Confirming eligibility for a specific combo product with the FSA/HSA account administrator before purchase is advisable.
Practical steps for coverage:
- Contact the insurance plan's member services line to ask whether a specific combo device is covered under DME benefits.
- Ask the prescribing doctor for a letter of medical necessity if submitting for insurance reimbursement.
- Check the device's FDA clearance status before submitting an insurance claim.
- Use FSA/HSA funds for out-of-pocket costs if insurance does not cover the device directly.
A doctor can advise on documentation needed to support an insurance claim for a home monitoring device.
Frequently Asked Questions
Is there a device that measures both blood glucose and blood pressure?
Yes. True 2-in-1 devices that measure both blood glucose and blood pressure exist, though the market is smaller than for dedicated devices. Examples include the FORA D40 series and the TD-3223. Some products marketed as combos are bundled kits containing two separate devices. Buyers should confirm whether a product is a genuinely integrated unit or a bundled set before purchasing.
Can an Omron blood pressure monitor also check blood sugar?
No. Omron manufactures blood pressure monitors and does not currently produce a blood glucose monitor or a 2-in-1 combo device. Some third-party sellers bundle Omron blood pressure monitors with separate glucometers from other brands and market them as a diabetes monitoring package. These are bundled kits, not integrated devices.
How do you use a 2-in-1 blood pressure and glucose monitor?
The two measurements require separate steps performed sequentially. For blood pressure: sit quietly for five minutes, apply the cuff to the upper arm at heart level, and start the measurement. For blood glucose: insert a test strip, use a lancing device to prick the fingertip, apply a small blood sample to the strip, and read the result. Many clinicians recommend taking the blood pressure reading first, before the finger prick, to avoid a stress-related increase in blood pressure. A doctor or diabetes educator can provide a personalized testing routine.
Are combo glucose and blood pressure monitors accurate?
Most combo devices are designed to meet the FDA's minimum standard for blood glucose accuracy (within 15--20% of a laboratory reference value) and basic blood pressure accuracy. Fewer combo devices have undergone the independent validation studies that leading standalone devices have completed. For most adults with stable, non-insulin-dependent type 2 diabetes and well-controlled hypertension, a validated combo device can provide clinically useful readings. A doctor can advise on whether the accuracy profile of a specific device is appropriate for an individual's treatment plan.
Keeping Readings in Context
A glucose reading and a blood pressure reading taken at home are data points, not diagnoses. Home monitors provide trend information that, combined with periodic lab tests and clinical visits, gives a more complete picture of how both conditions are being managed. Single readings that fall outside target ranges are worth noting but rarely call for immediate action on their own. A consistent pattern of out-of-range readings is the signal to bring to a care team.
For anyone managing both conditions and looking for practical tools to make sense of readings and next steps, the Momentary Lab AI healthcare navigator is one resource worth exploring. A doctor remains the appropriate person to interpret results and adjust any treatment plan.
References
- Laight DW. Hypertension and diabetes: shared risk factors. British Journal of Diabetes. 2018. https://www.bjd-abcd.com/index.php/bjd/article/view/36
- American Diabetes Association. Standards of Medical Care in Diabetes 2025 -- Hypertension and Cardiovascular Disease. https://diabetes.org/living-with-diabetes/treatment-care/high-blood-pressure
- American Diabetes Association. Standards of Medical Care in Diabetes 2025 -- Diabetes Technology. https://diabetes.org/living-with-diabetes/treatment-care/diabetes-technology
- American Heart Association. Monitoring Your Blood Pressure at Home. https://www.heart.org/en/health-topics/high-blood-pressure/understanding-blood-pressure-readings/monitoring-your-blood-pressure-at-home
- Omron Healthcare. Product Information. https://omronhealthcare.com/
- U.S. Food and Drug Administration. Do Not Use Smartwatches or Smart Rings to Measure Blood Glucose Levels: FDA Safety Communication. https://www.fda.gov/medical-devices/safety-communications/do-not-use-smartwatches-or-smart-rings-measure-blood-glucose-levels-fda-safety-communication
- Medicare.gov. Blood Sugar Monitors Coverage. https://www.medicare.gov/coverage/blood-sugar-monitors
- Internal Revenue Service. Publication 502: Medical and Dental Expenses. https://www.irs.gov/publications/p502
- Centers for Disease Control and Prevention. Diabetes Data and Statistics. https://www.cdc.gov/diabetes/php/data-research/index.html
- Association for the Advancement of Medical Instrumentation. Blood Pressure Device Validation. https://www.aami.org/
